SCHEMBL5846249

SCHEMBL5846249

O=C(O)CCNCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.58
MTNR1A P48039 1/20 0.56
MTNR1B P49286 1/20 0.56
CNR1 P21554 6/20 0.54
CNR2 P34972 5/20 0.54
EPHX2 P34913 2/20 0.54
HDAC3 O15379 3/20 0.54
HDAC4 P56524 3/20 0.54
HDAC1 Q13547 3/20 0.54
HDAC7 Q8WUI4 3/20 0.54
HDAC2 Q92769 3/20 0.54
HDAC10 Q969S8 3/20 0.54
HDAC11 Q96DB2 3/20 0.54
HDAC8 Q9BY41 3/20 0.54
HDAC6 Q9UBN7 3/20 0.54
HDAC9 Q9UKV0 3/20 0.54
HDAC5 Q9UQL6 3/20 0.54
HTR2A P28223 1/20 0.50
HRH1 P35367 1/20 0.50
CASR P41180 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL329180 0.87 MTNR1A (0.58) KCNH2MTNR1AMTNR1BCNR1CNR2
SCHEMBL7390885 0.84 KCNH2 (0.53) KCNH2MTNR1AMTNR1BCNR1CNR2
SCHEMBL11796932 0.84 KCNH2 (0.76) KCNH2MTNR1AMTNR1BCNR1CNR2
SCHEMBL13917984 0.83 GRIN1 (0.58) MTNR1AMTNR1BCNR1CNR2EPHX2
SCHEMBL27322889 0.82 CASR (0.62) MTNR1AMTNR1BCNR1CNR2EPHX2
Hydrochloric Acid SCHEMBL11794831 0.82 KCNH2 (0.73) KCNH2MTNR1AMTNR1BCNR1CNR2
Glycine SCHEMBL27555842 0.81 MTNR1A (0.51) KCNH2MTNR1AMTNR1BCNR1CNR2
SCHEMBL3172518 0.80 MTNR1A (0.59) KCNH2MTNR1AMTNR1BCNR1CNR2
SCHEMBL3674189 0.80 CYP2D6 (0.54) MTNR1AMTNR1BCNR1CNR2EPHX2
SCHEMBL12329367 0.79 CNR1 (0.57) KCNH2MTNR1AMTNR1BCNR1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366698-A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor Galapagos SAS (FR) 2011-09-21 EP disclosed
US-7501429-B2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents QUEEN'S UNIVERSITY AT KINGSTON (CA) 2009-03-10 US disclosed
US-7501429-B2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents QUEEN'S UNIVERSITY AT KINGSTON (CA) 2009-03-10 US disclosed
US-6995177-B1 HCV NS3 protease inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2006-02-07 US disclosed
EP-1230260-B1 HCV NS3 PROTEASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2003-09-17 EP disclosed
EP-1230260-A1 HCV NS3 PROTEASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2002-08-14 EP disclosed
WO-2001032691-A1 HCV NS3 PROTEASE INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2001-05-10 WO disclosed